Close
13/12/2017
ALBA Synchrotron Works for People’s Health
Two recent works remind us that ALBA synchrotron is a very valuable tool to help develop new drugs.

On one hand, using the MIRAS beam line of the ALBA synchrotron (infrared radiations), researchers from the Universitat Autònoma de Barcelona (UAB) and the ALBA Synchrotron have demonstrated in a paper the capability of metalosomes - aggregates made of phospholipids and metal complexes - to interact with cells and release carbon monoxide in a controlled way (CO release can be beneficial because of its anti-inflammatory, vasodilator and cardio protective properties).
 
On the other hand, in another publication, a team led by researchers from the Universitat Politècnica de Catalunya (UPC) has unveiled the mechanism of action of two drugs, FR60 and JNI18, which cure 100% of mice with sleeping sickness. Using X-rays of the ALBA XALOC beam line, they have observed how these drugs perfectly stacked on the Trypanosoma brucei’s DNA, the parasite that causes the disease (image). Blocking and inflicting specific damage on its DNA, the parasite cannot reproduce and finally dies after 4-5 days.
 

More news

10/06/2015 The Barcelona Synchrotron Park in the SmartReFlex European project 01/06/2015 SENER and ALBA sign a technology transfer agreement 28/05/2015 Synchrotron light applications for the pharmaceutical industry 20/05/2015 Financial Times ranks ESADE 7th worldwide in open executive education programmes 14/05/2015 Joint promotion in Korea of the Barcelona Synchrotron Park and the Parc Científic de Barcelona 07/05/2015 The UAB ranks well
32 33 34 35 36 37 38 39 40 41 42